Friday, June 17, 2011

"Ted L. Nancy’s Afternoon Stories" Now on Kindle

Barry Marder Joyous, Elated, & One More Thesaurus Word!

Glendale, CA, June 17, 2011 - Ted L. Nancy, author of the "Letters From A Nut" hit comedy books, announces that "Ted L. Nancy's Afternoon Stories" is now available on Kindle.

Read on your computer or other mobile devices. Get Kindle for iPhone, iPad, Android, BlackBerry, PC and Mac. You can have it in seconds.

In this new book, Ted travels to people’s workplaces telling them stories they do not want to hear. And brings along acts they do not want to see!

Such as: THE VENTRILOQUIST WITH THE PUPPET IN A COMA. The puppet just lays there hooked up to a hospital IV. The Ventriloquist talks to him but he just beeps there unresponsive.

"I misjudged," says Ted. "I assumed people wanted to hear my stories such as THE BATHROOM ATTENDANT WHO FINALLY PASSED OUT and see my acts. I had no idea someone would curse me in French. I am sorry for that person. He must have some good in him though."

The book has photos & illustrations by Alan Marder. Phyllis Murphy is Mr. Nancy's muse. She does not care for spumoni. Ted’s website is TEDLNANCY.COM


For inquiries contact Eric Bjorgum, Ted's Norwegian attorney.

Contact:
Mr. Eric Bjorgum
Ted L. Nancy
Glendale, CA 91201
213-785-8070

Using Customer Lifecycle Engagement to Improve Email Marketing

Join us on 23rd June 2011 to discover best practice lifecycle engagement techniques

Shenley Wood, Milton Keynes, June 17, 2011 - RedEye today announces the next in its series of concise, free digital marketing webinars - ‘Using Customer Lifecycle Engagement to Improve Email Marketing’.

Due to popular demand, following on from the success of this presentation at TFM&A 2011, RedEye’s Commercial Director Matthew Kelleher will be repeating his seminar on lifecycle engagement as a webinar, on Thursday 23rd June. Don’t miss your final chance to attend this innovative presentation.

The webinar is designed to show marketers how to implement lifecycle engagement email strategies to improve conversion and ROI.

The best way to improve conversion through email marketing is to create engaging email campaigns based on where customers are in the customer lifecycle. Through tactically segmenting data, marketers can create engaging campaigns to target users, from first time browsers to repeat customers.

Join us online and find out how to improve results by turning your email marketing programmes into a long term engagement strategy:

Determine how to engage customers and improve conversion for the long term.

Discover how to integrate the right strategies at the right time to maximise engagement and increase ROI.

Learn how to build a lifecycle engagement strategy that will improve conversion, long term.

Matthew will also include retail/travel client case studies in this presentation from Haven Holidays and Evans Cycles.

How to Attend To register for free visit: http://www.ondemand.redeye.com/learning-centre/webinars/

Title: Using Customer Lifecycle Engagement to Improve Email Marketing

Date: 23rd June

Time: 3pm-3.30pm

Speaker: Matthew Kelleher

About the speaker:
A Masters graduate in Economics from the LSE, Matthew worked for Acxiom for 16 years, starting at NDL, Claritas and most latterly Acxiom. He undertook a variety of divisional director roles, most notably launching Claritas Interactive in 1999 and overseeing its European development. A founder member of the DMA Email Council, Matthew is responsible at RedEye for the service and delivery of email solutions for all clients as well as for the growth of the business.

Press Contacts:
Katie Traynier, Marketing Manager: katie.traynier@redeye.com, 01908 340 903

About RedEye:
RedEye is the leader in behavioural email. RedEye has been helping online companies improve conversion since 1997, providing an integrated service of email marketing, web analytics and website usability.

In 2001 RedEye launched the first behavioural email campaign for William Hill. Behavioual email integrates web analytics with email marketing to produce highly targeted emails based on online user behaviour. Today RedEye helps hundreds of online companies improve conversion using behavioural email, achieving results such as of 750% ROI and 10% online conversion. In 2010 RedEye launched Behavioural Email onDemand, a self service solution enabling online companies to run basic behavioural email campaigns such as basket abandonment.

By integrating analytics with usability RedEye offers a unique service of Conversion Rate Optimisation. This service provides a structured process to help online companies fully analyse customer behaviour, enabling marketers to make the correct changes or implement the right strategies to improve online conversion.

RedEye previously won the NMA Award for ‘Best Use of Email’ and was shortlisted in the Econsultancy Innovation Awards for ‘Innovation in Email Marketing’.

RedEye currently has 3 UK offices (London, Milton Keynes and Crewe) and has just launched its first European Office in Dusseldorf, Germany. RedEye clients include French Connection, Haven Holidays, Hotel Chocolat, ASOS, Monarch, Butlins, HSBC and Ted Baker.

Contact:
Katie Traynier
Marketing Manager
26 Shenley Pavilions
Chalkdell Drive
Shenley Wood
Milton Keynes MK5 6LB
01908 340 903

Oxford Expression Technologies Launches VLP Vaccine Production Services

Oxford Expression Technologies, the award-winning specialist provider of baculovirus-based protein expression solutions, now applies its expertise to the production of recombinant vaccines, particularly in the field of virus like particle (VLP) vaccines.

Oxford, UK, June 15, 2011 - Oxford Expression Technologies, the award-winning specialist provider of baculovirus-based protein expression solutions, now applies its expertise to the production of recombinant vaccines, particularly in the field of virus like particle (VLP) vaccines. VLP vaccines represent the next generation of treatment methodologies; the VLP platform offers huge potential for use as a highly effective antiviral vaccine.

The secret to virus like particle vaccines is their ability to mimic the structure of a real virus. After vaccination with these mimics, an individual’s immune response reacts largely as it would to the real virus, but due to the absence of genetic material the VLP vaccine is unable to replicate and is therefore harmless to the vaccinated individual. VLP production requires high yields of multiple virus structural proteins to form complex structures. The expression system needed to produce these structures must be both safe and capable of producing proteins both on a small (testing) and large scale (vaccine production). These requirements are ideally suited to Oxford Expression Technologies highly efficient and scalable baculovirus protein expression system (flashBAC).

Passing comment, Richard Broadhead, Sales and Marketing Manager at Oxford Expression Technologies said, "Baculovirus Expression systems overcome many of the problems associated with VLP production, the FDA has recently licensed a baculovirus produced VLP vaccine for use in humans (Cervarix® by GlaxoSmithKline), paving the way for further baculovirus based VLP production," he continued, "Oxford Expression Technologies is uniquely placed to apply its existing baculovirus expertise to this exciting new field of virus like particle vaccines."

Oxford Expression Technologies invites anyone with an interest in VLP vaccines to please visit their website - http://oetltd.com/articles/news-press/news-stories/vaccine-vlp.html
Oxford Expression Technologies is a biotechnology company specializing in the use of baculovirus vectors, a eukaryotic expression system that can express a large variety of recombinant proteins. Oxford Expression Technologies provides protein expression products, services and consultancy to many global pharmaceutical companies. The Company’s proprietary flashBAC technology enables large amounts of a given protein to be produced in culture. Its internationally renowned expertise and products enable proteins to be produced faster, more easily and cost-effectively using automated and high-throughput methods compared with other baculovirus expression systems. This contributes to the development of new drugs and research targeted towards understanding how proteins work in health and disease.

The company was founded in 2007 as a result of collaboration between Oxford Brookes University and the Natural Environment Research Council to provide researchers with custom proteins for research purposes.

For Further information or an illustrative image:
Media contact - Mathew Taylor, Director, Algorythm Solutions Ltd, mobile: +44 (0)773 403 2112, email: mtaylor@algorythmsolutions.com, website: www.algorythmsolutions.com

Contact:
Mathew Taylor
Director
Algorythm Solutions Ltd
10 Torkington St
Stamford, Lincolnshire PE9 2UY
+44 (0)773 403 2112

Expert Opinion Verifies Revolutionary New steel Making Process for Astra Mining

Astra Mining, an Australian diversified mining company, has received an independent expert opinion from Hungary’s University of Miskolc confirming the potential of its revolutionary new steel manufacturing process.

North Headline, SA, June 17, 2011 - The end product, T-Steel, is significantly stronger than regular steel and provides vast production, operational and environmental benefits.

T-Steel was used commercially to strengthen steel for non-civilian use. Astra has taken the opportunity with the devolution of the Eastern bloc countries to acquire the technology and roll it out globally.

Astra Mining CEO, Dr. Jaydeep Biswas, says the independent verification of the steel’s unique properties comes from one of the University of Miskolc’s leading metallurgical engineers, Professor Emeritus Dr. Farkas Otto.

"This expert opinion on a study into the preparation of the production of T-Steel confirms it has better qualities compared to traditional steels," Dr. Biswas says.

"It also confirms the CO2 emission in its manufacture can be up to two times less than with traditional steel making technologies, reducing a manufacturing plants carbon footprint which is highly beneficial to the environment.

"Astra has a substantial 30 percent ownership of T-Steel’s IP and has full operational and management control of its business, so we are very excited to receive this independent verification."

T-Steel is a direct, high category replacement for the currently produced equivalent steel types and has immediate benefits in high use countries such as China and India. It can also play a large role in countries trying to reduce C02 emissions such as Australia.

The basic product, which includes the use of unique alloy based formulas invented over a 30 year period in Hungary, is based on a process which can modify the metallurgical properties of steel at a molecular level.

"T-Steel can be produced by existing steel mills with little or no retrofitting needed, however this can only be done if the mills have access to the T-Steel technology and the correct steel plant operation conditions," Dr. Biswas says.

"This makes T-Steel nearly impossible to replicate, as attempts to meet all necessary conditions would cost many hundreds of millions, something that would not be cost effective for individual steel manufacturing companies.

"Astra is in negotiations for a long term co-operation agreement with one the world’s largest steel traders for the DAM Steel Works in Hungary which will produce 500,000 tonnes per annum of T-Steel annually.

"The acquisition of DAM Steel plant is not a pre-requisite for rollout for the T-Seel technology, it is one part of a comprehensive business plan, however the relationship would position Astra ideally to capitalise on its strategic growth plan and market T-Steel products worldwide."

The viability of the T-Steel technology has been verified by extensive independent reporting and the technology is commercially viable due to its strong record of commercial applications, including areas in construction, automotive and machinery.

Companies that have already utilised T-Steel technology in the past include those in vehicle manufacturing and industrial applications.

"A Top 4 accounting firm completed the financial model for the valuation of T-Steel, which is based on a single manufacturing mill producing 500,000 tonnes of steel per annum and a separate business unit distributing the alloy-based formula globally," Dr. Biswas says.

"It is estimated that the project of global commercialisation of T-Steel technology has a NPV over A$6.12 billion, assuming the level of risk is in line with industry average.

"Based on the 30 percent IP ownership, Astra’s share is extremely valuable to our company."

Astra Mining’s global portfolio includes gold and tin interests in south east Asia and southern India, coal mines in Australia, iron ore in India, and the production of a new high-strength steel technology.

Astra has also confirmed its plans to list on the Frankfurt Stock Exchange before the end of August.

For more information visit www.astramining.com or email investor-relations@wedgewoodcommunications.com

Contact:
Caitlin Petrou
Astra Mining
46 Tynte Street
North Headline, SA 5006
+61 (0) 402 823 343